Oral ARV-1801 Given in Combination With Intravenous Ceftazidime or Meropenem for Treatment of Melioidosis in Hospitalized Patients

NCT05105035 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

125

Enrollment

INDUSTRY

Sponsor class

Conditions

Melioidosis

Interventions

DRUG: Ceftazidime or meropenem
DRUG: ARV-1801
DRUG: Placebo

Sponsor

Arrevus Inc.

Collaborators

[object Object]